Extract clinical trial data, drug approval records, regulatory filings, formulary listings, pipeline intelligence, and medical literature from FDA, CDSCO, EMA, ClinicalTrials.gov, PubMed, and global drug information platforms. Structured pharma data for life sciences research, investment intelligence, and competitive strategy.
Pharmaceutical data scraping is the automated collection of structured life sciences intelligence from publicly accessible regulatory databases, clinical trial registries, drug information platforms, academic literature repositories, and pharma company sources. The public domain contains an enormous volume of commercially and scientifically valuable data: every clinical trial registered with ClinicalTrials.gov or the EU Clinical Trials Register, every drug approval and rejection decision published by the FDA, EMA, CDSCO, or other national regulators, every marketed drug's label and prescribing information, and decades of peer-reviewed research published in journals indexed by PubMed. Scraping this data systematically — with the right normalisation and linkage layer — transforms scattered public information into a structured pharmaceutical intelligence platform.
For pharma companies, biotech firms, and life sciences investors, this data is operationally critical. Clinical pipeline monitoring tells you where competitors are investing their R&D resources. Regulatory approval tracking reveals which therapeutic areas regulators are prioritising and how approval timelines are trending. Formulary data shows which drugs are covered by payers and at what tier — directly influencing commercial launch strategies. Literature mining surfaces emerging scientific evidence that may precede clinical development activity. Taken together, these data streams constitute a comprehensive view of the pharmaceutical competitive and regulatory landscape.
DataFlirt's pharma data scraping infrastructure handles the specific technical characteristics of life sciences data sources. Regulatory databases like the FDA's drug databases, CDSCO's public portal, and the EMA's product database are updated on irregular schedules and require careful monitoring for new filings and amendments. ClinicalTrials.gov and international trial registries contain highly structured data in standardised formats but require significant normalisation to be useful for cross-registry analysis. Medical literature from PubMed requires entity recognition to link publications to drugs, targets, and disease areas. We handle all of this with purpose-built extractors and normalisation pipelines.
Critically, pharmaceutical data scraping operates exclusively in the public domain. We collect only data that regulatory authorities, trial sponsors, and publishers have chosen to make publicly available — which in the pharmaceutical industry is substantial, driven by regulatory transparency requirements and open science mandates. This makes pharma one of the richest verticals for legitimate data intelligence, and DataFlirt's pipelines are designed to harvest this public information responsibly and comprehensively.
Comprehensive extraction built for reliability, accuracy, and scale.
Extract trial registrations, protocol details, enrollment status, site locations, primary endpoints, and results postings from ClinicalTrials.gov, EU CTR, CTRI, and all major registries.
Monitor FDA NDA/BLA approvals, EMA CHMP opinions, CDSCO decisions, and national agency actions — with structured extraction of indication, label, and approval condition details.
Scrape drug product information including approved indications, dosing, contraindications, warnings, and drug interaction data from public label repositories.
Track IND filings, NDA submissions, REMS requirements, orphan drug designations, fast track grants, and breakthrough therapy designations from public regulatory dockets.
Aggregate research abstracts, full-text papers, citation networks, and author affiliations from PubMed, bioRxiv, medRxiv, and journal publisher sites — linked to drug and disease entities.
Extract public drug pricing data, formulary tier listings, prior authorisation criteria, and step therapy requirements from payer and government drug databases.
Every field you need, structured and ready to use downstream.
A proven process that turns any source into clean structured data — reliably.
{ "status": "success", "source": "clinicaltrials.gov", "scraped_at": "2025-03-19T10:00:00Z", "trial": { "nct_id": "NCT06118541", "title": "Phase III Study of Compound X in NSCLC", "sponsor": "AstraZeneca", "phase": "Phase 3", "status": "Recruiting", "condition": "Non-Small Cell Lung Cancer", "intervention": "Osimertinib + Compound X", "enrollment": 480, "start_date": "2024-09-01", "primary_completion": "2027-06-01", "primary_endpoint": "Progression-Free Survival", "sites": 42, "countries": ["US","IN","DE","JP"] } }
Built on proven open-source tools and cloud infrastructure — no vendor lock-in.
FDA drug labels, EMA EPARs, and CDSCO approvals extracted from PDF into structured fields using layout-aware document parsing.
Named entity recognition identifies drugs, targets, diseases, and genes in unstructured text and links them to standard identifiers (RxNorm, MeSH, UniProt).
Continuous monitoring of regulatory databases detects new approvals, label amendments, safety communications, and filing status changes.
Trials registered across multiple registries (ClinicalTrials.gov, EU CTR, CTRI, ANZCTR) matched and deduplicated into unified trial records.
High-volume literature collection via Entrez API supplemented by publisher site scraping for full-text, citation counts, and author affiliation data.
Indications normalised to ICD-10, drug names to INN and RxNorm, and targets to standard gene nomenclature for cross-source analytical consistency.
From solo analysts to enterprise data teams — here's how organizations use this data.
Regulatory transparency requirements mean the pharmaceutical industry generates more publicly accessible structured data than almost any other sector. Clinical trial protocols, regulatory review documents, drug labels, safety communications, and academic literature are all public — but scattered across dozens of sources in inconsistent formats. DataFlirt builds the extraction and normalisation infrastructure that transforms this scattered public record into a structured intelligence platform — giving life sciences teams the analytical foundation they need to make faster, better-informed decisions.
Start free and scale as your data needs grow.
For small teams and projects getting started with data.
For growing teams with serious data requirements.
For large organizations with custom requirements.
Everything you need to know before getting started.
Join data teams worldwide using DataFlirt to power products, research, and operations with reliable, structured web data.
